Bitget App
Mag-trade nang mas matalino
Buy cryptoMarketsTradeFuturesEarnSquareMore

HKEX:6922 stock price forecast

How will HKEX:6922 stock perform in 2026 and 2030?

This page primarily displays the projected price range for HKEX:6922 stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of HKEX:6922, the development trends of Cryofocus Medtech (Shanghai) Co. Ltd. Class H, and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for HKEX:6922. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Cryofocus Medtech (Shanghai) Co. Ltd. Class H's financial performance and industry trends to provide short-term price predictions for HKEX:6922 stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year HKEX:6922 stock price forecast

Price target:
10.53 HKD
+78.47%
Based on 1-year price forecasts from 63 analysts, the highest estimate is 14.17 HKD, while the lowest estimate is 5.95 HKD.

Analyst rating for HKEX:6922

Based on ratings from 68 analysts over the past three months, the overall consensus is Sell.

Strong buy
9
Buy
10
Hold
17
Sell
27
Strong sell
5

FAQ

How has HKEX:6922's EPS performed recently?

HKEX:6922's EPS is projected to reach -- HKD next quarter. Explore more Cryofocus Medtech (Shanghai) Co. Ltd. Class H financial data and stay up to date on the company's latest developments on the HKEX:6922 stock details page.

What is the revenue forecast for HKEX:6922 next quarter?

Cryofocus Medtech (Shanghai) Co. Ltd. Class H's revenue is projected to reach -- HKD in the next quarter. You can view Cryofocus Medtech (Shanghai) Co. Ltd. Class H's revenue and earnings on the HKEX:6922 stock details page.

What is the price target for HKEX:6922?

Based on analyst estimates, the most likely target price for HKEX:6922 over the next 12 months is 10.53 HKD, with a projected high of 14.17 HKD and a projected low of 5.95 HKD. To track whether this target is reached within the next year, you can view the HKEX:6922 stock price chart on the HKEX:6922 stock details page to check the current HKEX:6922 stock price, or follow the latest developments related to HKEX:6922 on the HKEX:6922 Stock News page.

What is the analyst rating for HKEX:6922?

We collected ratings from 68 analysts who have evaluated HKEX:6922 stock over the past three months. Most analysts maintain a Sell outlook, and after aggregating all opinions, the overall consensus rating is Sell. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of HKEX:6922 stock in 2030?

Based on price forecasts and analyses of Cryofocus Medtech (Shanghai) Co. Ltd. Class H from Wall Street analysts and major investment banks, HKEX:6922 is projected to trade between 11.80 HKD and 59.00 HKD in 2030.

HKEX:6922 stock price change

Sa huling araw ng trading, HKEX:6922 sarado ang stock sa 5.90 HKD, na may pagbabago sa presyo ng -0.34% para sa araw.

Trade stock futuresHKEX:6922 stock details

Tungkol kay Bitget

Ang unang Universal Exchange (UEX) sa mundo, na nagbibigay-daan sa mga gumagamit na mag-trade hindi lamang ng mga cryptocurrency, kundi pati na rin ng mga stock, ETF, forex, gold, at mga real-world asset (RWA).
Learn more
HKEX/
HKEX:6922 stock price forecast